Stockreport

NanoVibronix Highlights Second Quarter Revenue Growth and Narrowing of Loss from Operations in Letter to Stockholders

NanoVibronix, Inc.  (NAOV) 
NASDAQ:AMEX Investor Relations: otcmarkets.com/stock/naov/profile
PDF ELMSFORD, N.Y.--(BUSINESS WIRE)--NanoVibronix, Inc. (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acous [Read more]